Ansocot, Bb Boy -.
HRN: 27-01-88 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/28/2025
05/05/2025
IV
38mg
Q24H
PSNB
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes